Self-Esteem Scores Soar One Year After Metabolic, Bariatric Surgery
TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with higher postoperative weight loss, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 15 to 19 in Washington, D.C.
Justin Dhyani, M.D., from Geisinger Medical Center in Danville, Pennsylvania, and colleagues examined changes in patients' internalized weight stigma before and after MBS. Patients aged 18+ who underwent primary bariatric surgery from 2006 to 2019 were identified (5,749 patients). They completed the Impact of Weight Quality of Life questionnaire (iwQOL) survey preoperatively and at 12 months. The seven-item self-esteem score from the iwQOL was used to assess weight stigma.
The researchers found that for the overall group and within each surgery type, self-esteem scores increased significantly (33.6 to 77.5 overall), with the smallest change for biliopancreatic diversion with duodenal switch (+31.6). Smaller increases in self-esteem scores were seen for patients with higher versus lower preoperative body mass index (+34.8 versus +46.9 for BMI of 50 kg/m2 versus 40 kg/m2). A greater improvement in self-esteem scores was seen for patients with higher postoperative weight loss. No statistically significant differences in change in weight stigma were seen for sex, age, or race/ethnicity.
"Understanding weight stigma and psychosocial factors associated with obesity is essential to offering holistic care," Dhyani said in a statement. "While these factors should not dictate the decision to have bariatric surgery, they should be an important part of the conversation."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Patients With Extreme Obesity Face Limitations to Accessing Specialty Care
TUESDAY, Sept. 30, 2025 -- Patients weighing more than 450 lb face considerable limitations when attempting to access specialty care, according to a research letter published...
GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis
TUESDAY, Sept. 30, 2025 -- Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have better long-term outcomes compared with those taking...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.